查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765050

全球細胞裂解/細胞分離市場

Cell Lysis / Cell Fractionation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球細胞裂解/細胞分餾市場規模將達到 49 億美元

全球細胞裂解/細胞分離市場規模預計在2024年為36億美元，預計到2030年將達到49億美元，2024年至2030年的複合年成長率為5.6%。哺乳動物細胞是本報告分析的細分市場之一，預計其複合年成長率為6.5%，到分析期結束時規模將達到25億美元。微生物細胞細分市場在分析期間的複合年成長率預計為5.1%。

美國市場規模估計為 9.583 億美元，中國市場預期複合年成長率為 5.3%

美國細胞裂解/細胞分餾市場規模預計在2024年達到9.583億美元。作為世界第二大經濟體，中國預計2030年市場規模將達到7.746億美元，2024-2030年的複合年成長率為5.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為5.2%和4.6%。在歐洲，預計德國的複合年成長率為4.2%。

全球細胞裂解/細胞分餾市場－主要趨勢與促進因素摘要

細胞裂解對於解答生物學問題是否至關重要？

細胞裂解是生物學研究中的基本技術，對於破壞細胞以釋放其內部內容物（包括蛋白質、DNA、RNA 和細胞器）至關重要。這個過程是許多實驗工作流程中關鍵的第一步，包括基因組學、蛋白質組學和代謝代謝體學，在這些實驗中，分析細胞成分對於了解生物過程、疾病機制和治療標靶是必不可少的。細胞裂解可以透過機械、化學或酶方法來實現，這取決於被裂解細胞的類型和下游應用。超音波和均質化等機械方法通常用於破壞堅固的細胞類型，例如細菌和植物細胞，而溶菌酶處理等酶促方法則常用於更精細的樣品，以確保精細的生物分子得以保存。細胞裂解的成功直接影響所得細胞級分的質量，因此選擇正確的方法至關重要。多年來，裂解技術的創新提高了細胞內容物的產量和純度。這在蛋白質精製和用於序列測定的核酸萃取等高精度應用中尤其重要。因此，細胞破碎仍然是研究和工業生物生產中的重要工具，使科學家能夠在分子層面上解剖和理解生命的內部運作。

為什麼細胞分離對於研究亞細胞結構至關重要？

細胞分離是細胞裂解後分離細胞成分的過程，對於研究單一細胞器和大分子的功能和結構至關重要。細胞裂解後，使用離心等分離技術分離各種亞細胞成分，例如細胞核、粒線體、內質網和細胞質。這對於理解能量產生、蛋白質合成和細胞凋亡等細胞過程尤其重要，因為在這些過程中必須分離和研究特定細胞器的作用。超速離心和密度梯度分離技術的進步使得這些成分的分離更加精確，使研究人員能夠詳細研究它們的生化特性和相互作用。細胞分離在神經生物學和癌症研究等領域至關重要，因為細胞器的行為極大地影響疾病的進展和治療反應。此外，細胞分離也廣泛應用於藥物研發，因為分離細胞器可以幫助科學家更深入了解藥物的作用機制和代謝途徑，最終開發出更有針對性的治療方法。隨著亞細胞分析需求的增加，細胞分餾技術不斷發展，以支持各個生物醫學領域對細胞成分的詳細探索。

技術進步如何影響細胞裂解和分餾？

技術創新極大地改變了細胞​​裂解和分離的格局，使這些過程更加高效、可擴展且精確。其中最顯著的進展之一是自動化系統的開發，該系統能夠實現高通量細胞裂解，從而簡化了藥物研發和基因組學等大規模研究的工作流程。這些自動化系統最大限度地減少了人為錯誤並降低了差異性。這在處理精細樣品或需要確保多個實驗之間一致性時至關重要。此外，電穿孔和壓力循環技術等新型非機械裂解技術應運而生，為傳統方法提供了更為溫和的替代方案，並降低了蛋白質變性和脆弱細胞成分受損的風險。這些創新在蛋白質體學中尤其重要，因為保持蛋白質完整性對於下游分析至關重要。在分離方面，微射流的進步使得在微尺度上更精確地分離細胞成分成為可能，減少了樣品損失並提高了組件純度。這為單細胞分析打開了新的大門，在單細胞分析中，微量的細胞物質必須格外小心處理。此外，將機器學習演算法融入分離過程，提高了我們根據特定細胞特徵預測和最佳化分離結果的能力。此類進展正在推動該領域的發展，確保細胞裂解和分離始終處於分子生物學研究的前沿。

是什麼推動了細胞裂解和分餾市場的成長？

細胞裂解和分離市場的成長受到多種因素的推動，包括生物技術的進步、個人化醫療需求的不斷成長以及蛋白質組學和基因組學研究範圍的不斷擴大。隨著生物製藥產業持續開發標靶治療，尤其是針對癌症和神經退化性疾病的療法，對高精度細胞裂解和分離工具的需求呈指數級成長。自動化高通量裂解系統等技術進步使研究人員能夠更快速且有效率地處理大量樣本，這在藥物研發和臨床診斷等領域至關重要。單細胞分析日益受到關注，這需要研究人員分離和分析單一細胞的內容物，這也推動了對更複雜的裂解和分離技術的需求。此外，蛋白質體學在理解複雜生物系統方面的興起，也推動了對能夠準確分離和保存蛋白質複合物的先進分離技術的需求。消費行為也發揮作用，因為患者和醫療保健提供者正在尋求更個人化、更精準的治療方案，而這些方案依賴這些技術提供的詳細細胞和分子數據。此外，製藥業對生技藥品生產和品管的監管要求，也推動了強大的細胞裂解和分離解決方案的應用，以確保藥物生產流程符合嚴格的標準。這些因素，加上生命科學研究投資的不斷增加，預計將在未來幾年推動細胞裂解和分離市場的成長。

部分

組件（消耗品、設備）、類型（哺乳動物細胞、微生物細胞、其他類型）、最終用戶（研究機構/實驗室、製藥/生物技術公司、其他最終用戶）

受訪公司範例

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica LLC
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP10947

Global Cell Lysis / Cell Fractionation Market to Reach US$4.9 Billion by 2030

The global market for Cell Lysis / Cell Fractionation estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Mammalian Cells, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Microbial Cells segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$958.3 Million While China is Forecast to Grow at 5.3% CAGR

The Cell Lysis / Cell Fractionation market in the U.S. is estimated at US$958.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$774.6 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Cell Lysis / Cell Fractionation Market - Key Trends and Drivers Summarized

How Is Cell Lysis Essential to Unlocking Biological Research?

Cell lysis is a foundational technique in biological research, essential for breaking open cells to release their internal contents, such as proteins, DNA, RNA, and organelles. This process is a critical first step in many experimental workflows, including genomics, proteomics, and metabolomics, where the analysis of cellular components is required to understand biological processes, disease mechanisms, and therapeutic targets. Cell lysis can be achieved through mechanical, chemical, or enzymatic methods, depending on the type of cells being lysed and the downstream application. Mechanical methods, such as sonication or homogenization, are often used to disrupt tougher cell types like bacterial or plant cells, while enzymatic approaches, like lysozyme treatment, are common for more delicate samples, ensuring the preservation of sensitive biomolecules. The success of cell lysis directly impacts the quality of the resulting cellular fractions, which makes choosing the appropriate method crucial. Over the years, innovations in lysis techniques have improved the yield and purity of cellular contents, which is particularly important in high-precision applications like protein purification and nucleic acid extraction for sequencing. Cell lysis, therefore, remains a vital tool in both research and industrial bioproduction, allowing scientists to dissect and understand the inner workings of life at a molecular level.

Why Is Cell Fractionation Crucial for Studying Subcellular Structures?

Cell fractionation, the process of separating cellular components after lysis, is indispensable for studying the function and structure of individual organelles and macromolecules. Once the cells have been lysed, fractionation techniques, such as centrifugation, are used to separate the various subcellular components like the nucleus, mitochondria, endoplasmic reticulum, and cytoplasm. This is particularly important in understanding cellular processes such as energy production, protein synthesis, and apoptosis, where the roles of specific organelles must be examined in isolation. Advances in ultracentrifugation and density gradient fractionation have enabled more precise isolation of these components, allowing researchers to study their biochemical properties and interactions in great detail. In fields like neurobiology and cancer research, where the behavior of cellular organelles can significantly influence disease progression and treatment responses, cell fractionation is essential. Moreover, cell fractionation has wide applications in the development of pharmaceuticals, as isolating organelles allows scientists to better understand drug mechanisms and metabolic pathways, ultimately guiding the development of more targeted therapies. As the need for subcellular analysis grows, cell fractionation continues to evolve, supporting the detailed exploration of cellular components in various biomedical fields.

How Are Technological Innovations Shaping Cell Lysis and Fractionation?

Technological innovations have dramatically transformed the landscape of cell lysis and fractionation, making these processes more efficient, scalable, and precise. One of the most notable advancements is the development of automated systems that allow for high-throughput cell lysis, streamlining workflows in large-scale studies such as drug discovery and genomic research. These automated systems minimize human error and reduce variability, which is crucial when working with sensitive samples or when consistency is required across multiple experiments. Additionally, novel non-mechanical lysis techniques, such as electroporation and pressure cycling technology, have emerged, offering gentler alternatives to traditional methods and reducing the risk of protein denaturation or damage to fragile cellular components. These innovations are particularly valuable in proteomics, where maintaining the integrity of proteins is critical for downstream analysis. On the fractionation front, advancements in microfluidics have enabled more precise separation of cellular components at the microscale, reducing sample loss and improving the purity of the fractions. This has opened new doors for single-cell analysis, where tiny amounts of cellular material must be handled with extreme care. Moreover, the integration of machine learning algorithms into fractionation processes is enhancing the ability to predict and optimize fractionation outcomes based on specific cellular characteristics. These technological developments are driving the field forward, ensuring that cell lysis and fractionation remain at the cutting edge of molecular biology research.

What Is Driving Growth in the Cell Lysis and Fractionation Market?

The growth in the cell lysis and fractionation market is driven by several factors, including advancements in biotechnology, rising demand for personalized medicine, and the expanding scope of proteomics and genomics research. As the biopharmaceutical industry continues to develop targeted therapies, particularly for cancer and neurodegenerative diseases, the need for high-precision cell lysis and fractionation tools has grown exponentially. Technological advancements, such as automated and high-throughput lysis systems, are making it easier for researchers to process large numbers of samples quickly and efficiently, which is critical in fields like drug discovery and clinical diagnostics. The increasing focus on single-cell analysis, where researchers need to isolate and analyze the contents of individual cells, is also driving demand for more sophisticated lysis and fractionation technologies. Additionally, the rise of proteomics in understanding complex biological systems is fueling the need for advanced fractionation techniques that can isolate and preserve protein complexes with high fidelity. Consumer behavior is also playing a role, as patients and healthcare providers push for more personalized and precise treatment options, which depend on the detailed cellular and molecular data that these technologies provide. Furthermore, regulatory requirements for biologics production and quality control in the pharmaceutical industry are encouraging the adoption of robust cell lysis and fractionation solutions to ensure that drug manufacturing processes meet stringent standards. These factors, coupled with increased investment in life sciences research, are expected to continue driving the growth of the cell lysis and fractionation market in the coming years.

SCOPE OF STUDY:

The report analyzes the Cell Lysis / Cell Fractionation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Consumables, Instruments); Type (Mammalian Cells, Microbial Cells, Other Types); End-Use (Research Laboratories & Institutes, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica L.L.C.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Lysis / Cell Fractionation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Proteomics and Genomics Expands Market for Cell Lysis Solutions
    • Advancements in Non-Mechanical Lysis Technologies Propel Innovation in Cell Fractionation
    • Increasing Use of Cell Lysis in Drug Discovery Strengthens Market Growth
    • Growing Adoption of Cell Fractionation in Cancer Research Drives Demand for Advanced Lysis Techniques
    • Technological Innovations in Microfluidic-Based Lysis Create New Opportunities in Cell Fractionation
    • Expansion of Single-Cell Analysis Boosts the Need for Gentle and Precise Cell Lysis Methods
    • Rising Investment in Biopharmaceutical Research Fuels Growth in Cell Lysis Technologies
    • Growing Application of Cell Lysis in Protein Purification Accelerates Market Growth
    • Advances in Enzyme-Based Lysis Methods Drive Innovation in Cell Fractionation
    • Rising Demand for Efficient Organelle Isolation Techniques Expands Opportunities in Cell Fractionation
    • Emergence of Automated Lysis Systems Enhances Efficiency and Scalability in Research Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Mammalian Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Mammalian Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Microbial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Microbial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Cell Lysis / Cell Fractionation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION